Opioid Manufacturer Indivior's Former Global Medical Director
Outcome
OIG enforcement action against Opioid Manufacturer Indivior's Former Global Medical Director for controlled substance.
Details
Opioid Manufacturer Indivior's Former Global Medical Director — OIG Enforcement (2026)
OIG took enforcement action against Opioid Manufacturer Indivior's Former Global Medical Director in 2026 involving controlled substance violations in the Small Manufacturers sector.
Violation types: Controlled Substance
Entity type: Healthcare Provider
Penalty type: Criminal
Source: Opioid Manufacturer Indivior's Former Global Medical Director Pleads Guilty In Connection With Drug Safety Claims
How Crucible Prevents This
Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works